News Briefs

When the size, shape, color and markings on their prescription pills change without explanation, it can hamper patients’ medication adherence, according to a study published on Aug. 12 in the American Journal of Managed Care. The study outlined results of two 2016 surveys: one conducted on patients 50 years and older taking generic drugs for depression, diabetes, epilepsy, HIV, hyperlipidemia or hypertension, and one conducted on licensed pharmacists. The pharmacists acknowledged that pill appearance changes frequently in their pharmacies, and more than three-fourths of respondents reported notifying patients about those changes often, either verbally or through a sticker on pill bottles. Yet less than half of patient respondents reported being notified of pill-appearance changes — something 82% said they would prefer pharmacists do. “Among patients who reported experiencing a change, 12% reported stopping their medication or using it less frequently,” the study said. Read more at https://bit.ly/3aVUbxD.

Humana Inc. is suing a Florida-based company called QuivvyTech and multiple doctors, alleging that they ran an “organized, elaborate telemedicine scheme” targeting Humana members. According to the suit, which was filed on Aug. 20, telemarketers cold-called Humana members and “tricked them into talking about common ailments,” then sent that information to doctors who electronically prescribed high-cost topical creams to the members without ever actually speaking to them. The fraudulent prescriptions were then wired to the co-conspirator pharmacies, which dispensed the medications to the targeted members and “billed Humana millions of dollars for these fraudulent prescription claims,” the complaint alleged. Humana members, meanwhile, “often were left confused, irate and in the possession of unwanted expensive creams.” View the lawsuit at https://bit.ly/34vL0Tx.

© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-Merck-COVID-19-Drug-Could-Gain-Emergency-Use-Authorization.jpg
October 14

Merck COVID-19 Drug Could Gain Emergency Use Authorization

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-More-MA-PD-PDP-Members-Will-Be-in-4-Star-Plans-in-2022.jpg
October 14

More MA-PD, PDP Members Will Be in 4-Star Plans in 2022

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-PhRMA-Blasts-Poll-About-Govt-Drug-Price-Negotiation-Support.jpg
October 14

PhRMA Blasts Poll About Gov’t Drug Price Negotiation Support

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today